TCB-32 (Compound I-1) is a FGFR1 agonist with an EC50 of 0.88 µM. TCB-32 significantly increases cell proliferation through activating FGFR1 signaling pathway as bFGF and its downstream ERK 1/2 with excellent thermal stability. TCB-32 can replace bFGF in serum-free cell culture media. TCB-32 can be used for tissue repair and wound healing related diseases like psoriasis and eczema research[1][2].
Molekulargewicht:
708.78
CAS Nummer:
[352513-86-1]
Formel:
C32H40N18O2
Target-Kategorie:
ERK,FGFR
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
